Long Term Real-World Patient-Reported Outcomes with Risanki-zumab in Patients with Moderate to Severe Psoriasis From the CorEvitas Psoriasis Registry

被引:0
|
作者
Strober, Bruce E. [1 ,2 ]
Ferris, Laura K. [3 ]
Duffin, Kristina Callis [4 ]
Janak, Jud C. [5 ]
Sima, Adam P. [5 ]
Eckmann, Thomas [5 ]
Patel, Manish [6 ]
Photowala, Huzefa [6 ]
Garg, Vishvas [6 ]
Armstrong, April W. [7 ]
机构
[1] Yale Univ, New Haven, CT USA
[2] Cent Connecticut Dermatol Res, Cromwell, CT USA
[3] Univ Pittsburgh, Pittsburgh, PA USA
[4] Univ Utah, Dept Dermatol, Salt Lake City, UT USA
[5] CorEvitas LLC, Waltham, MA USA
[6] AbbVie Inc, N Chicago, IL USA
[7] Univ Southern Calif, Los Angeles, CA USA
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:AB189 / AB189
页数:1
相关论文
共 50 条
  • [31] Disease characteristics and patient reported outcomes in psoriasis patients treated with secukinumab in a real world setting: Results from the Corrona Psoriasis Registry
    Strober, Bruce
    Herrera, Vivian
    Hur, Peter
    Karki, Chitra
    Mason, Marc A.
    Siu, Kimberly
    Lebwohl, Mark
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB102 - AB102
  • [32] Psoriasis Impact on Patient-Reported Outcomes in Psoriatic Arthritis in a Real-World Setting: Results from the APOPSIS Study
    Athanassiou, Panagiotis
    Theodoridou, Athina
    Koukli, Eftychia Maria
    Georgountzos, Athanasios
    Vlachoyiannopoulos, Panagiotis
    Kallitsakis, Ioannis
    Sakkas, Lazaros
    Dapola, Aikaterini Matsouka
    Gazi, Souzana
    Georgiou, Panagiotis
    Gorecki, Patricia
    Gkamaloutsos, Christos
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [33] Real-world effectiveness of persistent tralokinumab use on clinician and patient-reported outcomes in patients with atopic dermatitis in the CorEvitas atopic dermatitis registry
    Silverberg, Jonathan
    Balu, Sanjeev
    Choi, C. Jean
    Li, Alvin
    Pugach, Oksana
    Schneider, Shannon
    Simpson, Eric
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [34] Patient-reported Outcomes and Burden of Disease in Paediatric Patients with Psoriasis: Real-world Data from EU5 and US
    Seyger, Marieke M. B.
    Paller, Amy S.
    Sticherling, Michael
    Bachhuber, Teresa
    Thomas, Nicolas
    Hetherington, James
    Lucas, James
    Richardson, Craig
    Augustin, Matthias
    ACTA DERMATO-VENEREOLOGICA, 2023, 103
  • [35] Patient-reported outcomes and burden of disease in paediatric patients with psoriasis: real-world data from the EU5 and USA
    Seyger, M.
    Paller, A.
    Sticherling, M.
    Bachhuber, T.
    Fang, J.
    Hetherington, J.
    Lucas, J.
    Meakin, S.
    Richardson, C.
    Augustin, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (01) : E28 - E29
  • [36] Characteristics and disease burden in patients with mild to moderate vs severe plaque psoriasis in real-world settings: Results from the Corrona Psoriasis Registry
    Strober, Bruce
    Cronin, Angel
    Lin, Tin-Chi
    O'Brien, Jaqueline
    Emeanuru, Kelechi
    Kang, Hyung-Joo
    Gomez, Natalie Nunez
    Khilfeh, Ibrahim
    Lebwohl, Mark
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB113 - AB113
  • [37] Real-World Outcomes of Adalimumab Treatment for Moderate and Severe Psoriasis in Korean Patients (RAPSODI Study)
    Kim, Dong Hyun
    Son, Sang Wook
    Jeong, Ki-Heon
    Ahn, Jiyoung
    Lee, Eun-So
    Kim, Il-Hwan
    Ha Lee, Un
    Park, Hai-Jin
    Ko, Joo Yeon
    Kim, Byung-Soo
    Kim, Jin Ju
    Rashid, Javed
    Kim, Kwang Joong
    ANNALS OF DERMATOLOGY, 2023, 35 (02) : 107 - 115
  • [38] Depression and anxiety in patients with psoriasis treated with brodalumab: Real-world patient-reported outcome study
    Ohata, Chika
    Murotani, Kenta
    Kanai, Yasumasa
    Imafuku, Shinichi
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB128 - AB128
  • [39] Effect of apremilast on patient-reported outcomes in patients with moderate to severe plaque psoriasis in the ESTEEM 1 trial
    Armstrong, A. W.
    Griffiths, C.
    Tencer, T.
    Li, S.
    Zhang, F.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 : 67 - 67
  • [40] Changes in patient-reported outcomes with etanercept treatment following apremilast failure in patients with moderate to severe psoriasis
    Bagel, Jerry
    Stolshek, Bradley S.
    Samad, Ahmed S.
    Yang, Yue
    Chung, James B.
    Kricorian, Gregory
    Kircik, Leon
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB180 - AB180